Rituximab yielded long-term benefit in lupus nephritis

PARIS – Treatment with rituximab in patients with refractory lupus nephritis was associated with significant long-term improvement in symptoms, histology, and laboratory markers in a prospective...

Field of Interest: Rheumatology
Type: News Item

Trial of sirukumab for lupus nephritis falls flat

PARIS – The investigational interleukin-6 blocker sirukumab provided no benefit to patients with lupus nephritis but put them at a very high risk of developing a serious infection in a small,...

Field of Interest: Rheumatology
Type: News Item

No blood clot risk found with HPV vaccination

The quadrivalent human papillomavirus vaccine does not increase the risk of venous thromboembolism, a study showed. Two previous studies finding an association, one based on the Vaccine Adverse...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness